MBRK Insider Trading Activity and SEC Form 4 Filings
MBRK insider trading summary
No open-market insider purchases or sales of MiddleBrook Pharmaceuticals, Inc. (MBRK) have been reported on SEC Form 4 in the past 12 months.
Latest MBRK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 17, 2009 | EGI-Fund (08-10) Investors, L.L.C. | 10% Owner | Buy | $830K (2,000,000 @ $0.41) |
| Dec 17, 2009 | Chai Trust Co LLC | 10% Owner | Buy | $830K (2,000,000 @ $0.41) |
| Dec 17, 2009 | Sz Investments LLC | 10% Owner | Buy | $830K (2,000,000 @ $0.41) |
| Dec 17, 2009 | Egi-Mbrk, L.L.C. | 10% Owner | Buy | $830K (2,000,000 @ $0.41) |
| Nov 26, 2007 | Edward M Rudnic | President and CEO | Sell | $3K (3,100 @ $1.12) |
| Nov 26, 2007 | Edward M Rudnic | President and CEO | Sell | $7K (6,585 @ $1.10) |
| Nov 26, 2007 | Edward M Rudnic | President and CEO | Sell | $2K (1,415 @ $1.11) |
| Nov 26, 2007 | Edward M Rudnic | President and CEO | Sell | $327 (300 @ $1.09) |
| Nov 23, 2007 | Edward M Rudnic | President and CEO | Sell | $208 (200 @ $1.04) |
| Nov 23, 2007 | Edward M Rudnic | President and CEO | Sell | $2K (2,200 @ $1.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.